當(dāng)前位置：首頁(yè) SCI期刊 SCIE期刊醫(yī)學(xué) 中科院4區(qū) JCRQ3 期刊介紹(非官網(wǎng))

Ophthalmic EpidemiologySCIE

國(guó)際簡(jiǎn)稱：OPHTHAL EPIDEMIOL 參考譯名：眼科流行病學(xué)

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q3

基本信息：: ISSN：0928-6586; E-ISSN：1744-5086; 是否OA：未開(kāi)放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：NETHERLANDS; 出版商：Taylor and Francis Ltd.; 出版語(yǔ)言：English; 出版周期：Bimonthly; 出版年份：1994; 研究方向：醫(yī)學(xué)-眼科學(xué)

評(píng)價(jià)信息：: 影響因子：1.7; H-index：56; CiteScore指數(shù)：3.7; SJR指數(shù)：0.981; SNIP指數(shù)：1.048

發(fā)文數(shù)據(jù)：: Gold OA文章占比：16.67%; 研究類文章占比：95.77%; 年發(fā)文量：71

投稿咨詢加急見(jiàn)刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見(jiàn)問(wèn)題

英文簡(jiǎn)介Ophthalmic Epidemiology期刊介紹

Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.

期刊簡(jiǎn)介Ophthalmic Epidemiology期刊介紹

《Ophthalmic Epidemiology》自1994出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見(jiàn)解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：較慢,6-12周
醫(yī)學(xué)
OPHTHALMOLOGY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Ophthalmic Epidemiology Cite Score數(shù)據(jù)

CiteScore：3.7
SJR：0.981
SNIP：1.048

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Ophthalmology	Q2	45 / 137	67%
大類：Medicine 小類：Epidemiology	Q3	76 / 148	48%

CiteScore 是由Elsevier(愛(ài)思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Ophthalmic Epidemiology 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	OPHTHALMOLOGY 眼科學(xué)	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開(kāi)始，這個(gè)分區(qū)只是為了方便圖書(shū)管理及圖書(shū)情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Ophthalmic Epidemiology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：OPHTHALMOLOGY	SCIE	Q3	52 / 95	45.8%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：OPHTHALMOLOGY	SCIE	Q3	52 / 95	45.79%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門(mén)類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Annual direct economic burden and influencing factors of dry eye disease in Central China
Author: Luo, Yanzhu; Yang, Wanju; Qi, Mengying; Wang, Yuhong; Li, Shaowei; Wang, Mingwu; Zeng, Qingyan

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 2, pp. 121-128. DOI: 10.1080/09286586.2021.1959618
2、Factors Associated with the Spectacle Wear Compliance among Primary School Students with Refractive Error in Rural China
Author: Du, Kang; Zhu, Jiaqi; Guan, Hongyu; Zhang, Yunyun; Wang, Huan; Wang, Decai; Shi, Yaojiang

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 1, pp. 17-26. DOI: 10.1080/09286586.2022.2028295
3、Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Author: Chen, Yize; Lohfeld, Lynne; Song, Di; Pak, Clara; Gong, Xia; Zhou, Wenzhe; Liang, Yuanbo; Congdon, Nathan

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 1, pp. 74-81. DOI: 10.1080/09286586.2022.2029500
4、Refractive Error in a Chinese Population with Type 2 Diabetes: A Report from the Fushun Diabetic Retinopathy Cohort Study
Author: Lin, Zhong; Wen, Liang; Li, Dong; Moonasar, Nived; Zhai, Gang; Wang, Yu; Wang, Feng Hua; Liang, Yuan Bo

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 1, pp. 38-45. DOI: 10.1080/09286586.2022.2031228
5、A Systematic Review of Clinical Practice Guidelines for Age-related Macular Degeneration
Author: Han, Xiaotong; Chen, Yanxian; Gordon, Iris; Safi, Sare; Lingham, Gareth; Evans, Jennifer; Keel, Stuart; He, Mingguang

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 3, pp. 213-220. DOI: 10.1080/09286586.2022.2059812
6、The Association between Dual Sensory Impairment and Hospital Admission in California Medicare Beneficiaries
Author: Wong, Yuen Sum Kylie; Tseng, Victoria L.; Yu, Fei; Coleman, Anne L.

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 2, pp. 166-172. DOI: 10.1080/09286586.2022.2084116
7、The Diagnostic Value of Circulating VEGF in Diabetic Retinopathy in Asia: A Systematic Review and Meta-analysis
Author: Liu, Xiaobing; Zhou, Xiaoping; Song, Weiqiong; Zeng, Jiechun; Niu, Xiuxiu; Meng, Ran

Journal: OPHTHALMIC EPIDEMIOLOGY. 2023; Vol. 30, Issue 3, pp. 230-238. DOI: 10.1080/09286586.2022.2088805
8、Barriers, Costs, and Attitudes Toward Pediatric Cataract Surgery at Two Large Facilities in China and India.
Author: Wang J¹, Jin L¹, Lu Q², Borah RR², Ali R², Li J³, Chakraborti C⁴, Kumar M⁴, Pan J⁵, Gilbert C⁶, Congdon N^1,^2,⁷.

Journal: Ophthalmic Epidemiol. 2019 Feb;26(1):47-54. doi: 10.1080/09286586.2018.1513043. Epub 2018 Aug 24.